APA (7th ed.) Citation

Stringer, M., Abeysekera, I., Dria, K. J., Roper, R. J., & Goodlett, C. R. (2015). Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model. Pharmacology, Biochemistry & Behavior, 138, 70. https://doi.org/10.1016/j.pbb.2015.09.002

Chicago Style (17th ed.) Citation

Stringer, Megan, Irushi Abeysekera, Karl J. Dria, Randall J. Roper, and Charles R. Goodlett. "Low Dose EGCG Treatment Beginning in Adolescence Does Not Improve Cognitive Impairment in a Down Syndrome Mouse Model." Pharmacology, Biochemistry & Behavior 138 (2015): 70. https://doi.org/10.1016/j.pbb.2015.09.002.

MLA (9th ed.) Citation

Stringer, Megan, et al. "Low Dose EGCG Treatment Beginning in Adolescence Does Not Improve Cognitive Impairment in a Down Syndrome Mouse Model." Pharmacology, Biochemistry & Behavior, vol. 138, 2015, p. 70, https://doi.org/10.1016/j.pbb.2015.09.002.